Community Reservoirs of Extended-Spectrum Beta-Lactamase-producing and Multi-Drug Resistant Enterobacterales
Project Number1R01AI179686-01A1
Former Number1R01AI179686-01
Contact PI/Project LeaderLOGAN, LATANIA K.
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Project Summary
Enterobacterales are increasingly resistant to multiple antibiotics, making them a global epidemic public health
threat. Multi-drug resistant Enterobacterales (MDR Ent) infections were historically limited to healthcare settings,
but over the past two decades there have been significant increases in infections occurring in otherwise healthy
children and adults without prior healthcare contact. These community-acquired (CA) MDR Ent strains are
epidemiologically and genetically distinct from healthcare-acquired strains, yet similarly associated with severe
infections, high costs, long hospital stays, subsequent nosocomial spread, and poor outcomes. Importantly, MDR
Ent strains have been recovered from multiple environmental and animal reservoirs, yet the contribution of these
sources to community-acquired human infection is unclear. We recently discovered that children residing in the
South and Southwest regions of Chicago had a striking 5-fold greater odds of CA-MDR Ent infection than children
living in the West region. Children residing in Central and Northwest Chicago had a >80% decreased odds of
such infections. Surprisingly, MDR Ent infections were 4-34x more likely to be community-acquired than were
infections with susceptible strains. This seeming paradox highlights critical gaps in knowledge of transmission
dynamics, reservoirs, sources, and origins of antibiotic resistance genes (ARGs) in CA-MDR Ent. Such
information is needed to inform strategies to interrupt community transmission. The clustering of CA-MDR Ent
infections in the South and Southwest Chicago “high-risk” regions makes it an ideal setting to investigate
environmental reservoirs of MDR Ent. The proposed studies will integrate genomic and epidemiologic data to
help define transmission pathways of MDR Ent. The proposal has two aims: 1) Profile MDR Ent and mobile
ARGs in Greater Chicago Area waterways and identify environmental reservoirs associated with community
acquisition of MDR Ent; 2) Assess risk factors for colonization with CA-MDR Ent and transmission dynamics of
CA-MDR Ent among community members located in established regions with high risk of infection. This will be
accomplished by: (1) sampling waterways and evaluating the relative contributions of key sources of
contamination (e.g., wastewater treatment plants, farms, and waterfowl) within the high-risk region relative to the
control (low-risk) region, (2) surveying the households of waterway users and residents in the high-risk region
for risk factors and MDR Ent colonization, (3) comprehensive multi-dimensional culture-, metagenomic (MGS)-,
and whole genome sequence (WGS)-based characterization of bacteria and ARGs within environmental, animal,
and human reservoirs to comprehensively track dissemination patterns of resistant genotypes. MGS and WGS
data will be compared across aims to identify sources of CA-MDR Ent. With knowledge generated through this
rigorous research, we can identify targeted interventions for reducing exposure to MDR Ent in healthy persons,
thereby decreasing infections, hospital admissions, healthcare costs and community spread of MDR Ent.
Public Health Relevance Statement
Project Narrative
Infections due to antibiotic-resistant bacteria known as Enterobacterales are occurring increasingly in the
community in otherwise healthy persons without significant prior health care contact. Our goal is to identify
community-based exposures to resistant bacteria by examining potential environmental, animal, and household
sources. Our results will lead to ways to control the sources that we find and to decrease the risk of antibiotic-
resistant bacterial infections in the community.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AdultAnimalsAntibiotic ResistanceAntibioticsAntimicrobial ResistanceAreaBacteriaBacterial Antibiotic ResistanceBacterial InfectionsBase SequenceChicagoChildChildhoodClinicalCommunitiesCommunity-Acquired InfectionsCyclophosphamideDataDimensionsEffectivenessEnvironmentEpidemicEpidemiologyEscherichia coliExposure toExtended-spectrum β-lactamaseFarmGenotypeGoalsHealth Care CostsHealthcareHomeHospitalizationHouseholdHumanIndividualInfectionInterruptionIntestinesKnowledgeLactamaseLength of StayLivestockLocationMediatingMetagenomicsMobile Genetic ElementsMulti-Drug ResistanceNational Institute of Allergy and Infectious DiseaseOutcomePathway interactionsPatternPersonsPlantsPlasmidsPredispositionPublic HealthRecreationReportingResearchResistanceRiskRisk AssessmentRisk FactorsRoleSamplingSourceStreamSurfaceSurveysTaxonomyUpdateVirulentWorkbacterial resistancebeta-Lactamaseclinically relevantcolistin resistancecommunity transmissioncompanion animalcomparison controlcostepidemiologic dataexposure reduction interventionsfluoroquinolone resistancegenomic datahealth care settingshealthcare-associated infectionshigh riskinfection riskmemberpreventresidenceresistance genetransmission processwhole genome
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
066469933
UEI
S352L5PJLMP8
Project Start Date
17-July-2024
Project End Date
30-June-2029
Budget Start Date
17-July-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$810,312
Direct Costs
$567,447
Indirect Costs
$242,865
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$810,312
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AI179686-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AI179686-01A1
Patents
No Patents information available for 1R01AI179686-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AI179686-01A1
Clinical Studies
No Clinical Studies information available for 1R01AI179686-01A1
News and More
Related News Releases
No news release information available for 1R01AI179686-01A1
History
No Historical information available for 1R01AI179686-01A1
Similar Projects
No Similar Projects information available for 1R01AI179686-01A1